OBJECTIVES: To use the PCR-RFLP-based linkage analysis for non-invasive prenatal diagnosis of β-thalassemia. BACKGROUNDS: Thalassemia is a prevalent genetic disorder occurring throughout the world. Cell-free fetal DNA (cffDNA) in the maternal plasma during pregnancy has been used to develop non-invasive prenatal screening and diagnostic tests. METHODS: PCR-RFLP for six SNPs in the β-globin gene was executed on paternal and maternal DNA as well as DNA extracted from CVS of the fetuses in seven β-thalassemic families. Based on the results, two families in which the paternal inherited SNPs in specifi c loci were different from the maternal one were selected and PCR-RFLP was performed on cffDNA extracted from the maternal plasma. RESULTS: Paternal SNPs in cffDNA were distinguished and the inheritance of paternally normal or mutant β globin allele was predicted by linkage analysis. CONCLUSION: The use of PCR-RFLP on cffDNA as a simple and inexpensive method was capable to provide similar results achieved by studying CVS of the fetuses. However, there is a limiting factor in this approach, namely that there is the little amount of cffDNA in maternal plasma. The PCR yield was improved either by adding BSA to PCR reaction or increasing the PCR cycles (Tab. 2, Fig. 2, Ref. 18) . Text in PDF www.elis.sk.
Introduction
β-thalassemiais one of the commonest autosomal recessive diseases with a high frequency in population of the Mediterranean area, Middle East, Indian subcontinent, Far East, Tropical Africa, and the Caribbean (1) . The β-globin gene cluster is located on human chromosome 11p15.5 including the genes arranged in the order 5'-ε-Gγ-Aγ-ψβ-δ-β-3'. The human β-globin gene complex spans a region of 70 kb and contains over 20 SNPs mostly detectable by RFLP analysis (2) .
Prenatal diagnosis of fetal genetic diseases based on the invasive methods such as chorionic villus or amniotic fl uid sampling increases the risk of fetal loss (3) . The discovery of cffDNA in maternal plasma has ushered an era for noninvasive prenatal diagnosis (4, 5) .
The concentration of fetal DNA in the maternal plasma is low and constitutes 10-20% of total DNA in maternal plasma (4, 6) . Also the maternal background DNA coexists with the cffDNA in the maternal plasma so it is diffi cult to distinguish between the maternally inherited fetal alleles and background alleles of the mother (3, 7, 8) . To tackle these issues the researchers have focused on paternally inherited alleles (9) , removing the maternally inherited alleles based on differential DNA methylation between fetus and mother (10), using gel electrophoresis to enrich the fetal DNA (8, 11) and applying digital PCR (12) or next generation sequencing (NGS) (12, 13) for assessment of the inheritance of the maternal mutant allele.
There are some reports of the analysis of mutations in β-globin gene with the purpose of non-invasive prenatal diagnosis using real-time PCR (14) , NGS (15) , arrayed primer extension (APEX) (16, 17) , allele-specifi c polymerase chain reaction (AS-PCR) (17) . Also the use of PCR-RFLP in cffDNA for noninvasive prenatal diagnosis of Achondroplasia is reported (18) .
Here we investigated the feasibility of prenatal exclusion of β-thalassemia major through the analysis of cffDNA. We used PCR-RFLP to track the transmission of paternal SNPs in cffDNA in families where the maternal SNP is different from the fetus's paternally inherited one. This enables us to differentiate between paternally mutant and normal alleles received by the fetus through linkage analysis.
Materials and methods

Patients
Seven β-thalassemic families undergoing prenatal diagnosis were initially screened to obtain suitable families enabling us to study the transmission of normal or mutant allele by linkage analysis. These couples gave their written consent after being briefed about the project. Two families met our criteria, in the sense that the mother was homozygous for a specifi c locus and the fetus inherited a different SNP from its father.
Genomic DNA extraction
DNA was extracted from 3 ml of peripheral blood from each couple by salting-out method.
Plasma separation
Additionally, 10 ml of maternal blood was collected into EDTA tubes (5 ml in each tube). After centrifuging the whole blood at 1600g for 10 minutes, the supernatant (plasma) was divided into several 1.5 ml micro tubes. For removing the residual cells, the second centrifugation was performed at 16,000 g for 10 minutes at 4 °C and the supernatant was transferred to fresh tubes.
cffDNA extraction
QIAamp DNA blood Maxi kit was used to extract the total cffDNA from maternal plasma using the manufacturer's protocol.
At the same time DNA was extracted from CVS using phenol chloroform method.
Primer design
The primer pairs were designed for six RFLP sites on β-globin gene cluster (Hinf I, RsaI, 3'ψβ/HindII, 5'ψβ/HindII, ε/Hind II, Ava II (Eco47I)) by using Gene Runner software. Due to the small size of cffDNA in maternal plasma, the sizes of PCR products were designed to be less than 200 bp (Tab. 1). s at 63 °C and 30 s at 72 °C, followed by incubation at 72 °C for 10 min. Digestion was carried out with the related restriction enzyme at each site. After obtaining the RFLP patterns in each locus, PCR-RFLP was executed on cffDNAs in families whose fetuses had distinguishable RFLP patterns in comparison with their mothers. In other words, the fetal DNA was -/+ and its mother was homozygous (-/-or +/+) for a specifi c locus (locus ε/Hind II in family 1 and locus 3'ψβ/Hind II in family 2).
PCR-RFLP
In order to improve the intensity of bands on the polyacrylamide gel, we increased the number of amplifi cation cycles up to 40 and/or used BSA (Bovine Serum Albumin) while keeping the amplifi cation cycles at 30.
Results
Both increasing the PCR cycles and using BSA enhanced the detection of the paternal alleles in DNA extracted from plasma. In the following, the pedigrees and the images of gel electrophoresis of PCR-RFLP products in two families are presented. In Figure 1 , paternal thalassemia allele which is linked to (-) chromosome has been transmitted to the fetus as identifi ed by testing CVS DNA. This has been similarly detected by assaying cffDNA. Therefore, the fetus has received a mutant paternal allele. In Figure 2 , the normal allele is linked to (+) chromosome. This allele was detected by both CVS and cffDNA. Therefore, the fetus has received a normal paternal allele.
Discussion
Due to the signifi cant risk of fetal miscarriage associated with invasive prenatal diagnosis, there has been an intensive search for the development of noninvasive prenatal diagnostic tests.
In this study, we aimed at demonstrating the feasibility of the use of PCR-RFLP for cffDNA-based noninvasive prenatal diagnosis. Nevertheless, due to low concentration of cffDNA in maternal plasma, the paternal allele may not be visible with few rounds of PCR cycles. So we increased the number of cycles up to 40. The more PCR cycles, the more intense bands on polyacrylamide gel were achieved. But since increasing the number of PCR cycles may result in non-specifi c amplifi cation, we also used BSA as a component of PCR reaction which resulted in increasing the PCR yields so that the paternal alleles were distinguishable even after 30 PCR cycles.
Since the SNPs used in our study are linked to the β-globin genes, we can investigate the inheritance of the paternally normal or mutant allele in the fetus using linkage analysis.
The limitation of this approach is that it cannot determine whether a fetus which is positive for a paternal mutation has β-thalassemia major or β-thalassemia minor. In such cases more investigation is needed to determine the fate of maternally inherited allele too in order to provide proper diagnosis for the fetus in question. So this method can be used as an initial noninvasive screening tool.
In family 1, the negative RFLP allele was linked to the mutant β-globin gene. Since the fetus has inherited this negative allele, it has inherited the paternally mutant β-globin gene too which is similar to the result obtained by CVS of the same fetus.
In family 2, the positive RFLP allele is linked to the normal β-globin gene. So the fetus has inherited the paternally normal β-globin gene.
In conclusion, we have been able to determine the transmission pattern of paternal SNPs to the fetus using cffDNA. This paves the way to assess the status of the fetus with regards to its paternal alleles provided there are informative SNPs in the family. Since the chance of inheriting the normal paternal allele by the fetus is 50 %, one can predict that a half of the fetuses are not affected with major β-thalassemia. So through the exclusion of inheritance of the paternal mutation, the need for invasive prenatal diagnosis procedures could be eliminated in a half of these pregnancies. 
